Brett P. Monia
Chief Executive Officer at Ionis Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ionis Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cognition Therapeutics Inc. June 7, 202496.9%
-
Ionis Pharmaceuticals Inc. June 6, 202497.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Ionis Pharmaceuticals Inc. | Other | +98 | $51.31 | $5,028 |
| Jun 26, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +50,000 | $56.78 | $2,839,000 |
| Jun 26, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −50,000 | $80.59 | $4,029,500 |
| Jun 25, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +21,072 | $32.60 | $686,947 |
| Jun 25, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −21,072 | $78.49 | $1,653,941 |
| Jun 24, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +14,565 | $32.60 | $474,819 |
| Jun 24, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −14,565 | $78.41 | $1,142,042 |
| Jun 17, 2026 | Cognition Therapeutics Inc. | Grant or award | +25,000 | — | — |
| May 14, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +3,220 | $32.60 | $104,972 |
| May 14, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −3,220 | $78.68 | $253,350 |
| May 13, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +1,316 | $32.60 | $42,902 |
| May 13, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −1,316 | $78.01 | $102,661 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +34,103 | $60.89 | $2,076,532 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −16,512 | $75.47 | $1,246,161 |
| Mar 10, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −17,591 | $76.34 | $1,342,897 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.